Pronađeno: 1-1 / 1 radova

Autori: Deegan Patrick B

>> Prikaži sve rezultate

Naslov A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase (Article)
Autori Pastores Gregory M  Petakov Milan S  Giraldo Pilar  Rosenbaum Hanna  Szer Jeffrey  Deegan Patrick B  Amato Dominick J  Mengel Eugen  Tan Ee Shien  Chertkoff Raul  Brill-Almon Einat  Zimran Ari 
Info BLOOD CELLS MOLECULES AND DISEASES, (2014), vol. 53 br. 4, str. 253-260
Projekat Protalix BioTherapeutics; Pfizer
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX